Buy Molnupiravir tablet over the counter

Molnupiravir is an antiviral medicine approved for the treatment of COVID-19. The drug blocks the reproduction of the virus and prevents the development of a severe form of the disease. A five-day course of therapy reduces the risk of hospitalisation by more than 30%.

Molnupiravir’s range of use includes Omicron, Delta and other types of coronavirus infection. Experts predict that the drug will remain effective even when new strains of the pathogens emerge. Thanks to its versatility, you can feel protected even during pandemic exacerbations.

The medicine has been approved by the European Medicines Agency (EMA) and is available now. To buy Molnupiravir, please use our online pharmacy. We provide the fastest possible Australia delivery so you can start treating your coronavirus in good time.

What is Molnupiravir used for

Before October 2021, treatment of mild to moderate COVID-19 infection was mainly symptomatic and supportive. Doctors recommended resting, drinking plenty of fluids, taking antipyretics, and taking vitamins C and D. Sometimes antibiotics were prescribed to prevent bacterial complications.

Molnupiravir has become a more effective alternative to this type of treatment. It stops the progression of the coronavirus infection, preventing it from becoming severe. Taking the capsules reduces the chance of pneumonia and serious breathing problems.

The new medicine is particularly good for people who have a risk factor for developing COVID-19:

• Age over 60 years old;
• chronic kidney dysfunction;
• diabetes mellitus;
• obstructive pulmonary disease;
• obesity;
• malignant cancer disease.

A modern method of treatment helps to reduce the severity of your symptoms. Fever, breathlessness, headache and loss of energy will be much less of a problem soon after you start taking the medicine.

Doctors do not prescribe Molnupiravir for coronavirus, which is accompanied by a significant reduction in oxygenation. For this reason, the medicine is rarely used during hospital treatment.

Do not take the capsules as a prophylactic – they do not help prevent infection. Only buy Molnupiravir online after a positive test for coronavirus infection.

Using for other viral infections

Molnupiravir is currently only approved to treat COVID-19. However, in clinical trials, it has shown good results against other RNA viruses.

Seasonal and avian influenza

Every year, at least one flu outbreak is reported in Australia. Due to the regular emergence of new strains of the virus, it has not been possible for a long time to create a sufficiently reliable cure. To prevent a severe course of the disease, vaccines have been used:

• Vaccines, the composition of which had to be adapted to the current type of flu.
• Neuraminidase inhibitors that inhibit the spread of the virus. These can have serious side-effects and should be taken under a doctor’s supervision.
• Amantadines enhance the effects of other drugs but are not suitable for monotherapy.

With the advent of Molnupiravir, the fight against flu outbreaks will become easier. The drug disrupts the multiplication mechanism, which is common to all varieties of the virus. Therefore, in the near future, a short course of capsules will be sufficient to cure the disease.

Respiratory syncytial virus

This type of microorganism causes infections of the lower respiratory tract. The disease is accompanied by mild symptoms, but occasionally provokes bronchiolitis and pneumonia. A severe course of the disease in childhood increases the risk of developing bronchial asthma after adulthood.

Molnupiravir can speed up the treatment of illnesses caused by the respiratory syncytial virus. Using the medicine will make it easier to fight the dangerous germs and minimise the chance of complications.

Ebola

Ebolaviruses have caused several epidemics in countries in Africa and the Middle East. The last outbreak of Ebola haemorrhagic fever occurred in 2015. To date, an effective vaccine has been developed and Molnupiravir is planned to be used for the infection. Studies have shown that the antiviral remedy relieves the main symptoms of the infection and should reduce mortality by several times.

How Molnupiravir works

In the human body, the active ingredient Molnupiravir is transformed into an analogue of cytidine, a substance needed by viruses to reproduce. During the replication of the microorganism, the drug is incorporated into the RNA, which leads to mutations. Pathological changes caused by the absence of true cytidine most often lead to the death of the virus.

The mechanism of action of Molnupiravir overcomes the defences of the infectious agents. Exonucleases, which can replace damaged RNA elements, do not respond to the medicine. This increases the number of mutated viruses and improves the chances of recovery.

The active substance is rapidly eliminated from the body. Its concentration in the blood drops by 50% in just 3-4 hours. In order to achieve a stable therapeutic effect, it is important to take the capsules according to a schedule.

How Molnupiravir was developed

The active ingredient Molnupiravir was synthesised by Drug Innovation Ventures at Emory (DRIVE). A patent for the drug was first registered in 2018. It was originally planned to be used to treat equine encephalitis, but detailed research has opened up broader prospects. The drug has a strong antidote to a variety of RNA viruses, including SARS-CoV-2.

The rights to Molnupiravir were taken over by Merck, which continued testing. In June 2020, scientists found that the drug was effective in COVID-19. A human trial showed that taking the capsules reduced the number of hospital admissions by more than 30% and the mortality rate by a factor of 9.

Between October and December 2021, Molnupiravir was approved for use in the UK, Australia, Denmark and the US. Since the beginning of 2022, the demand for the antiviral drug has been increasing in worldwide. The original medicine comes under the brand name Lagevrio.

Pharmaceutical companies from India and Bangladesh have announced the launch of generics. The price of Molnupiravir has fallen with the introduction of the new medicines. Today, anyone can get reliable protection against coronavirus infection.

How to take Molnupiravir

Molnupiravir is given to patients with acute respiratory syndrome caused by SARS-CoV-2. A COVID-19 test should be done before you start taking it. Buy Molnupiravir or its generics should be used primarily by people who are prone to developing a severe form of the disease.

Molnupiravir for COVID-19 is taken at 800 mg every 12 hours for 5 days. Longer treatment may be harmful. If you miss a dose, it is not necessary to double it next time. If you are less than 10 hours late, use the medicine immediately and continue with the standard treatment schedule.

The antiviral agent should be taken orally with food or separately. The diet has no effect on the absorption of the active ingredient. Alcohol consumption during treatment is strictly prohibited.

Patients with renal or hepatic impairment do not need to reduce the dosage of the medicine. The standard treatment is also suitable for elderly people.
Continue to observe quarantine restrictions after therapy has ended. Lagevrio improves your health but does not guarantee elimination of the entire SARS-CoV-2 population. You can be a source of infection even in the absence of symptoms.

Contraindications to the use of the drug

Clinical studies have shown that Molnupiravir is not safe for children. Therefore, the drug is not prescribed:

• In paediatric practice. In children it may cause changes in bone and cartilage development and other side-effects.
• Pregnant women. Molnupiravir has teratogenic effects, causing developmental disorders and severe abnormalities in the foetus.
• Breastfeeding mothers. It is not known whether the drug passes into breast milk. As a precautionary measure, women who are breastfeeding should not take the antiviral medicine.

Patients of childbearing age are advised to use reliable contraception during treatment and for some time afterwards. Women can stop using contraception 4 days after the last dose and men can only use it after 3 months.

Molnupiravir should not be used by people who are hypersensitive to the effects of Molnupiravir. If you feel unwell after taking the capsules, tell your doctor immediately.

Research on the medicine is ongoing and the list of contraindications to its use may be extended.

Molnupiravir side effects

The chances of getting side effects while taking Molnupiravir are low. About 3% of patients complain about digestive disorders, nausea and diarrhoea. In 1% of cases, dizziness has been observed.

If you overdose, you are more likely to have side effects. If you accidentally take a large number of capsules, consult your doctor. In most cases, supportive therapy is enough to improve your well-being.

If you feel uncomfortable after taking a standard dose of Molnupiravir, tell your doctor. Based on your body’s individual reaction to the medicine, a specialist will adjust your treatment for coronavirus infection.

What other drugs can be used to treat COVID-19

Two other drugs, Favipiravir and Ivermectin, are being considered for treatment of the respiratory infection caused by the coronavirus. Preliminary estimates suggest that these drugs do not have the same potential as Merck’s Molnupiravir, but their research is ongoing.

Favipiravir

Developed in 2002 in Japan for the treatment of influenza. Favipiravir is also active against other RNA viruses, including SARS-CoV-2. Favipiravir is recommended for COVID-19 in certain countries.

Treatment with Favipiravir should be short because of the risk of side effects. Long-term treatment with Favipiravir increases the level of uric acid in the blood, which can have a negative effect on health.

Ivermectin

Unlike Molnupiravir, Ivermectin is an antiparasitic drug but can also block the replication of some viruses. Ivermectin also works on COVID-19 pathogens. In addition, the medicine has an anti-inflammatory effect and speeds up the regeneration of tissues damaged during the disease. Scientists are currently determining the optimal dose of Ivermectin, which would produce a long-lasting therapeutic effect and remain safe for health.

Frequently asked questions about Molnupiravir

Can I buy Molnupiravir in the Australia without a prescription?

The medicine is available without a doctor’s prescription in online pharmacies. To prevent possible negative effects on your body, read the instructions for the antiviral medicine before you buy it. Do not take Molnupiravir if you have any contraindications. You should note that treatment may only be started after a positive test for COVID-19. The drug is only available in statutory pharmacies with a prescription.

Is the medicine compatible with other treatments for coronavirus infection?

When taking Molnupiravir and similar drugs, you should not give up traditional treatments. Keep to bed rest, take antipyretics and vitamins. A combination of therapeutic measures will ensure a quick recovery and help avoid negative health consequences.

Where can I find the most affordable prices for Molnupiravir?

We offer the lowest prices for coronavirus medicine in Australia. Our service allows you to save not only money but also time. The order is processed and dispatched on the day of payment and delivery takes 5 working days. We cooperate with official representatives of the manufacturer Molnupiravir, which allows us to reduce prices and guarantee high quality products.

Is it possible to get well in 5 days with Molnupiravir?

Molnupiravir does not destroy the SARS-CoV-2 viruses but only limits their ability to multiply. This avoids the development of a coronavirus infection and hospitalisation. After a 5-day course of treatment, some symptoms of COVID-19 may persist, but the body will tolerate the disease more easily. The period of complete recovery is different for each patient.

Disclaimer

The information on this page is for information purposes only and does not replace consultation with your doctor. Always read the instructions before using Molnupiravir. The online pharmacy accepts no liability for any consequences of improper use.